ECSP993166A - SERTRALINA ORAL CONCENTRATE - Google Patents
SERTRALINA ORAL CONCENTRATEInfo
- Publication number
- ECSP993166A ECSP993166A ECSP993166A ECSP993166A EC SP993166 A ECSP993166 A EC SP993166A EC SP993166 A ECSP993166 A EC SP993166A EC SP993166 A ECSP993166 A EC SP993166A
- Authority
- EC
- Ecuador
- Prior art keywords
- provides
- present
- sertralina
- pharmaceutically acceptable
- concentrated
- Prior art date
Links
- VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 title abstract 3
- 239000012141 concentrate Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 2
- 229960002073 sertraline Drugs 0.000 abstract 2
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 abstract 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente invención proporciona una composición farmacéutica concentrada líquida esencialmente no acuosa para la administración oral, que contiene sertralina o una sal farmacéuticamente aceptable de la misma y uno o más excipientes farmacéuticamente aceptables. La presente invención tambien proporciona un uso de esta composición concentrada para preparar una solución acuosa de sertralina. Además, la presente invención proporciona un procedimiento de uso de esta composición concentrada para tratar o prevenir una diversidad de enfermedades o afecciones. Finalmente, la presente invención proporciona el compuesto metanosulfonato de (1S-cis)-4-(3,4-diclorofenil)-1,2,3,4-tetrahidro-N-metil 1 naftalenoamina.The present invention provides an essentially non-aqueous liquid concentrated pharmaceutical composition for oral administration, containing sertraline or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients. The present invention also provides a use of this concentrated composition to prepare an aqueous sertraline solution. Furthermore, the present invention provides a method of using this concentrated composition to treat or prevent a variety of diseases or conditions. Finally, the present invention provides the compound (1S-cis) -4- (3,4-dichlorophenyl) -1,2,3,4-tetrahydro-N-methyl 1 naphthalenoamine methanesulfonate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP993166 ECSP993166A (en) | 1999-10-05 | 1999-10-05 | SERTRALINA ORAL CONCENTRATE |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP993166 ECSP993166A (en) | 1999-10-05 | 1999-10-05 | SERTRALINA ORAL CONCENTRATE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP993166A true ECSP993166A (en) | 1999-11-29 |
Family
ID=42044154
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP993166 ECSP993166A (en) | 1999-10-05 | 1999-10-05 | SERTRALINA ORAL CONCENTRATE |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP993166A (en) |
-
1999
- 1999-10-05 EC ECSP993166 patent/ECSP993166A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2088312T3 (en) | CONTROLLED RELEASE FORMULATION CONTAINING TRAMADOL. | |
| AR035927A1 (en) | LACTAMA COMPOUND (N) - ((S) -2-HIDROXI-3-METHYLBUTIRILE) -1- (L-ALANINIL) - (S) -1-AMINO-3-METHYL-4,5,6,7-TETRAHYDRO -2H-3-BENZAZEPIN-2-ONA, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, PROCEDURE FOR THE INHIBITION OF THE B-AMYLOID PEPTIDE RELEASE AND / OR ITS SYNTHESIS THAT USES IT AND ITS USE FOR THE FABR | |
| DE69906518D1 (en) | DRUG DISPENSING SYSTEM CONTAINS A SOLID, SOLID, DRY-BASED BASIS | |
| AU2002225772A1 (en) | Therapeutic agents and methods of use thereof for treating an amyloidogenic disease | |
| BR0114799A (en) | Cyanophenoxy carboxylic acid compounds and compositions for releasing active agents | |
| UY27533A1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING OXIBUTININE | |
| BR0015624A (en) | Use of a compound, compound, pharmaceutical composition, and method of treatment or prophylaxis of human diseases or conditions | |
| BRPI0415953A (en) | oral controlled release dosage formulation, method of treating a disorder, set of controlled release dosage forms and method for administering the formulation | |
| GT199900015A (en) | PROCEDURE TO TREAT HEART FAILURE | |
| BR0113590A (en) | 7-oxopyridopyrimidines | |
| BR0211063A (en) | Salts of anticonvulsant derivatives | |
| PA8483301A1 (en) | SERTRALINA ORAL CONCENTRATE | |
| AR030630A1 (en) | PHARMACEUTICAL COMPOSITIONS | |
| AR029588A1 (en) | NEW FORM (R) -N- [5-METHYL-8- (4-METHYLIPIPERAZINE-1-IL) -1,2,3,4-TETRAHYDRO-2-NAFTIL] -4-MORFOLINOBENZAMIDA | |
| ECSP066318A (en) | COMPOSITION FOR THE RELEASE OF A WEAK BASE FOR AN EXTENDED PERIOD OF TIME | |
| ECSP993166A (en) | SERTRALINA ORAL CONCENTRATE | |
| BR0111743A (en) | Farnesyl transferase which inhibits 1,2-ringed quinoline enantiomer | |
| CO5700723A2 (en) | USE OF A SPECIFIC CYCLIC AMINE DERIVATIVE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS TO TREAT AND PREVENT CARDIAC INSUFFICIENCY | |
| DK0768083T3 (en) | Use of sertraline to treat patients with post myocardial infarction | |
| AR033807A1 (en) | USE OF (R) - (-) - 2- [5- (4-FLUOROPHENYL) -3-PIRIDYLMETHYLAMINOME] -CROMANO AND ITS ACCEPTABLE SALTS FOR PHYSIOLOGICAL USE, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS | |
| GEP20043377B (en) | Pharmaceutical Complex | |
| DK0863752T3 (en) | Use of alkylamine derivatives such as terbinafine in the manufacture of a medicament for the treatment of concomitant diseases of a helicobacter pylori infection. | |
| GT200000087A (en) | POLYMORPH FORMS OF A AZABICICLO CITRATE (2.2.2) OCTAN - 3 - AMINA AND ITS PHARMACEUTICAL COMPOSITIONS. | |
| UY28111A1 (en) | NEW ORAL IMMEDIATE RELEASE DOSAGE FORM | |
| AR022348A1 (en) | A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SYMPTOMS OF LOWER URINARY TRACT |